Image

2019 Cannabis Business Award's

Publication of the Year

WEDNESDAY, FEBRUARY 12, 2025

 

FMCPG HAS BEEN SERVING

AND REPRESENTING THE CANNABIS PHYSICIAN COMMUNITY

SINCE 2020

 

FMCPG MEETING

LINK BELOW 

JOIN TONIGHT'S  MEETING OF THE FMCPG
WEDNESDAY

FEBRUARY 12, 2025

THE

"FLORIDA MEDICAL CANNABIS

PHYSICIAN GROUP"

(FMCPG)

FOR ALL

"MEDICAL MARIJUANA DOCTORS"

AND "MMTC DIRECTORS ONLY "

 

 

DISCUSSION WILL INCLUDE:

 

LEGISLATIVE  AGENDA FOR 2025

 

TRUMP APPOINTMENTS EFFECT ON THE CANNABIS INDUSTRY IN FLORIDA 

 

REVIEW OF THE OMMU AND  CHANGES TO THE DOCTOR'S PATIENT INPUT PORTAL ON THE OMMU WEBSITE. 

DOCTORS WITHIN OUR GROUP WILL DISCUSS HOW THEY HAVE BEEN WORKING AROUND SOME OF THE CHANGES

 

REF'S ISSUES AND SOLUTIONS

 

USE THIS LINK TO JOIN TONIGHT'S MEETING, NO PRE- REGISTRATION REQUIRED 

 

CLICK HERE ON LINK BELOW

https://us02web.zoom.us/j/83316986292?pwd=4OKjhdhNc99QQ2nzqSdkxKvtIVNqaf.1

 

Meeting ID: 833 1698 6292
Passcode: 505047

JOIN TONIGHT'S FMCPG
MEETING

WEDNESDAY

FEBRUARY 12 2025
 
 

 MEDICAL CANNABIS PHYSICIAN

PROMOTION PACKAGE BY

CANNABIS NEWS FLORIDA 

 

ARTICLE: Physician will contribute an article of 350 words**. This article will appear in the Cannabis News Florida e-newsletter for one month (4 weeks).

 

E-MAIL BLAST: Cannabis News Florida will send out one e-mail blast promoting the Physician to the other physicians in three zip code areas or one city to be determined by the Physician. The Physician will supply the information for the email blast. The Article above can be used in the e-mail blast.

 

The cost of this program is ONLY $500.

 

NEW YEAR'S SPECIAL ONLY $350

 

**Cannabis News Florida will assign a writer for a telephone interview with the Physician and create the article to be published. Physician shall have the right to review and approve the article before publication for an additional cost of $100.

 

IF YOU ARE INTERESTED, PLEASE EMAIL ME AT CHARLES@CANNABISNEWSFLORIDA.COM OR CALL MY CELL AT 954-605-4785

 
 

NEWS FROM THE PAST WEEK

RELATING TO THE BUSINESS OF

MMTC'S

IN FLORIDA

 

Click on Company Logo to be Transferred to Web Site

Trulieve to Open Medical Cannabis Dispensary in Middleburg, Florida

New Clay County location will host grand opening celebration Friday, February 14th

TALLAHASSEE, Fla., Feb. 11, 2025  — Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company in the U.S., today announced the opening of a new medical cannabis dispensary in Middleburg, Florida.

A grand opening celebration will be held Friday, February 14, beginning at 9 a.m., featuring music, specials, discounts, and opportunities to register for upcoming patient education sessions.

“We are committed to providing value, delivering quality, and helping our customers enhance their lives through cannabis,” said Trulieve’s Chief Executive Officer Kim Rivers. “We are proud to expand access in Clay County and look forward to serving patients and caregivers at this new location.”

Trulieve Middleburg, located at 1539 Blanding Boulevard, will be open 9 a.m. – 8:30 p.m. Monday through Saturday and 11 a.m. – 8 p.m. on Sundays, offering walk-in and express pickup service.

READ MORE

 
 

CLICK HERE FOR MORE INFORMATION ABOUT THE SUNBURN CANNABIS PROMOTIONS

 
 

I'm a new Text block ready for your content.

 

I'm a new Text block ready for your content.

 

The Cannabist Company Introduces Popular Brand Seed & Strain to Maryland

Launch Marks 12th Market for Brand

NEW YORK– Jan. 28, 2025– The Cannabist Company Holdings Inc. (Cboe CA: CBST) (OTCQX: CBSTF) (FSE: 3LP) (“The Cannabist Company” or the “Company”), one of the most experienced cultivators, manufacturers and retailers of cannabis products in the U.S., announced today the launch of its brand Seed & Strain into the Maryland market.

Seed & Strain debuts in Maryland with 0.5-gram vape cartridges, at the Columbia Care location in Chevy Chase and gLeaf locations in Frederick and Rockville. Whole flower, pre-rolls and additional products will be available in the coming months pending regulatory approval. With the introduction of these products, Seed & Strain is now available in 12 markets across the country.

READ MORE

 

The Cannabist Company Expands Ric Flair Drip Partnership to New Jersey Market

Introducing Bold Flavors and Top-Tier Quality to the Garden State with All-In-One Vapes, Cartridges, and Infused Edibles

NEW YORK—Jan. 22, 2025– The Cannabist Company Holdings Inc. (Cboe CA: CBST) (OTCQX: CBSTF) (FSE: 3LP) (“The Cannabist Company” or the “Company”), one of the most experienced cultivators, manufacturers and retailers of cannabis products in the U.S., announced today the expansion of its partnership with Ric Flair Drip into the New Jersey market, building on the collaboration which kicked off late last year with the brand’s debut in Delaware. The signature cannabis brand co-founded by the iconic wrestling World Champion, Ric Flair, is part of Carma HoldCo Inc., a leading global house of brands.

The Ric Flair Drip collection makes its debut in New Jersey, offering a lineup of premium cannabis products that deliver bold flavor profiles and exceptional quality. Inspired by the charisma and larger-than-life spirit of the wrestling legend, the brand captures the essence of Ric Flair in every product. The launch features all-in-one 1-gram vapes and vape cartridges in four expertly curated flavors: Banana Belts, Mango Mania, Strawberry Strut, and Woo Watermelon. In addition, the collection introduces tasty cannabis-infused edibles, available in bold new flavors: Flairy Cherry, Figure Four Orange, and Watermelon Wooooo.

READ MORE

 

AYR Wellness Announces Transition of Jared Cohen to Board Observer

MIAMI, Feb. 07, 2025 — AYR Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) (“AYR” or the “Company”), a leading vertically integrated U.S. multi-state cannabis operator, announced the resignation of Jared Cohen from its Board of Directors (the “Board”) and transition to Board Observer.

Mr. Cohen commented, “I thank AYR’s Board for approving my transition to Board Observer as I take on new professional obligations unrelated to AYR Wellness and outside of the cannabis industry. I am grateful for the opportunity to serve on AYR’s Board and would like to reiterate my confidence in the Company and its leadership team.”

Louis Karger, Chairman of the Board at AYR, said, “We thank Jared for his service to AYR and look forward to continuing to engage with Jared as a Board Observer.”

READ MORE

 

AYR Wellness Announces Leadership Update

MIAMI, Feb. 03, 2025 — AYR Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) (“AYR” or the “Company”), a leading vertically integrated U.S. multi-state cannabis operator, announced that Brad Asher, the Company’s Chief Financial Officer, has provided notice of his resignation to the Company in connection with Mr. Asher’s pursuit of another opportunity. His resignation will be effective at a mutually agreed upon date following the Company’s filing of its 2024 annual financial statements.

The Company intends to provide further updates regarding the search for a new Chief Financial Officer in due course.

AYR interim CEO Steven M. Cohen commented, “Brad has helped to build AYR since its earliest days and lay the foundation that we will continue to build from. We thank him for his years of service to AYR and wish him luck in his future endeavors.”

“I am incredibly proud to have helped build AYR from its beginning in 2019 to the operating organization that it is today,” said Mr. Asher. “The Company remains in great hands with a strong foundation in place.”

READ MORE

 

AYR Wellness Appoints George Denardo as President

MIAMI, Jan. 27, 2025 — AYR Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) (“AYR” or the “Company”), a leading vertically integrated U.S. multi-state cannabis operator, today announced that George Denardo, AYR’s Chief Operating Officer, has assumed the role of President of the Company.

In his new role, George will oversee all company-wide operations, including with all retail, wholesale, purchasing, marketing, cultivation, and manufacturing.

“This is a well-deserved promotion that highlights George’s strong contributions to AYR, our confidence in his leadership, and the Company’s commitment to operational improvements via cross-functional collaboration and accountability,” said Steven M. Cohen, Interim CEO of AYR. “In his time at AYR, George has been instrumental in improving key cultivation and production metrics, streamlining and re-launching our brand portfolio, and building an updated platform to launch new and innovative products. We look forward to George applying his expertise to retail and cultivation, providing greater connectivity between various functions of our business and creating a single source of accountability.”

READ MORE

 
 
 
 
 
 
 
 
 

News iAnthus Strengthens Portfolio with $36.5M Sale of Select Arizona Assets to Sonoran Roots

Transaction Supports iAnthus’ Focus on Key Growth Markets While Maintaining Presence in Arizona
NEW YORK and TORONTO, Feb. 07, 2025  — iAnthus Capital Holdings, Inc. (“iAnthus” or the “Company”) (CSE: IAN, OTCQB: ITHUF), which owns, operates and partners with regulated cannabis operations across the United States, today announced that certain iAnthus subsidiaries entered into definitive agreements (the “Purchase Agreements”) with a leading Arizona cannabis operator, Pitchfork Enterprises, LLC d/b/a Sonoran Roots and its affiliates (“Sonoran Roots”), to sell three dispensaries and two processing/cultivation facilities in Arizona for aggregate consideration of approximately $36.5 million (the “Transaction”). This strategic transaction is part of the Company’s ongoing efforts to optimize its portfolio, strengthen its balance sheet, and focus on key markets with the greatest growth potential.

The Transaction includes two dispensaries, a processing facility and a cultivation/processing facility located in Mesa, Arizona, as well as one dispensary located in Phoenix, Arizona (collectively, the “Facilities”). These Facilities have consistently delivered high-quality cannabis products and experiences to their surrounding communities. The Transaction will allow iAnthus to redirect resources to its growth initiatives in Florida, Maryland, New Jersey, Massachusetts and New York while still maintaining a retail presence in Arizona with one dispensary in Mesa, Arizona.

READ MORE

 
 
 
 
 
 

FINO BRANDS, INC

 
 
 
 

PROSPERITY MEDICAL, LLC

 

THERATRUE FLORIDA

 

EDEN FLORIDA, LLC

 
 

Florida ranks #1 in transaction volume by state with 8 deals for the LTM period ended 2/7/2025, representing $152.4M in deal consideration.

California ranks second in total M&A transactions with 6 deals completed, representing $24.8M in deal consideration.

Colorado, Maryland, Nevada and Illinois tie for third with 3 deals completed. However, Colorado ranks #1 in total M&A transaction consideration with $299.1M in deals.


View This Week's Viridian Regional Deal Tracker For a Deeper Dive Into M&A and Capital Raise Transactions by State


Wondering What Your Cannabis Business Is Worth?  Contact Us We'll Give You the Facts From Our Proprietary Deal Data

 

About The Viridian Cannabis Deal Tracker

Launched in January 2015, and having analyzed more than $75B in deals, the Viridian Cannabis Deal Tracker is a proprietary data service that monitors and analyzes capital raise and M&A activity in the legal Cannabis, Hemp, and Psychedelics industries. Our insights help companies, investors, lenders and acquirers make informed capital allocation decisions.  Each week the Deal Tracker provides proprietary data and market intelligence on transactions, including:

- Deals by Industry Sector (Track the Flow of Capital and M&A Deals by Industry Sector)

- Deal Structure (Equity/Debt for Capital Raises, Cash/Stock/Earnout for M&A)

- Principals to the Transaction (Issuer/Investor/Lender/Acquirer)

- Key Deal Terms (Deal Size, Valuation, Pricing, Warrants, Cost of Capital)

- Deals by Location of Issuer/Buyer/Seller (Track the Flow of Deals by State and Country)

- Credit Ratings (Leverage and Liquidity Ratios)


Contact
Scott Greiper
CEO
Viridian Capital Advisors, LLC
646.330.0704
sgreiper@viridianca.com

 
 

NATIONAL AND INTERNATIONAL NEWS

 

Tilray Brands Enhances Global Cannabis Supply Chain

Tilray Increases Industry-Leading Capacity to Meet Global Demand, Driving Growth Across Canada and Europe
NEW YORK and LEAMINGTON, Ontario, Feb. 10, 2025 — Tilray Brands, Inc. (“Tilray” or “Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of beverage, cannabis and wellness industries, today announced the completion of Phase I of its accelerated growth plan for its cannabis supply chain, which began with increased planting in late 2024. Phase II of the growth plan includes planting the outdoor cultivation site in Cayuga this spring. Tilray’s primary Canadian production facilities, Aphria One and Aphria Diamond, are now fully planted and positioned to capture the growing demand from Canadian and International cannabis markets. Certain sections of Aphria One, which were previously idled during the COVID-19 pandemic, are now back online.

These sites are projected to produce an additional 60 metric tonnes of cannabis annually, increasing Tilray’s current Canadian cannabis cultivation capacity to 210 metric tonnes per year and supplying both Canadian and International markets, including Europe, to meet rising global demand. Tilray expects the first sales of the Phase I harvests to occur late in the second half of our fourth quarter and the Phase II harvest to begin in October 2025.

READ MORE

 

Jushi Announces Support of Adult-Use Cannabis in Pennsylvania Governor’s Annual Budget Proposal and Address

BOCA RATON, Fla., Feb. 04, 2025  — Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCQX: JUSHF), a vertically integrated, multi-state cannabis operator, made the following statement regarding the inclusion of adult use cannabis in Pennsylvania Governor Josh Shapiro’s annual budget proposal and address.

“Jushi and its subsidiaries’ hundreds of employees here in the Commonwealth of Pennsylvania are pleased that the legalization of cannabis is once again a priority for the legislative session. And while we agree that there are important budget implications to this policy, it is also critically important to extend public protections of the regulated medical market we’ve created to the adult use marketplace.

READ MORE

 

SweetWater Brewing Launches Dive Beer: A Perfect No Frills, Satisfying, Crisp Lager

ATLANTA, Feb. 04, 2025  — SweetWater Brewing Company (“SweetWater Brewing” or “SweetWater”), the largest craft brewer in the Southeast and a Tilray Brands, Inc. company (NASDAQ: TLRY and TSX: TLRY) proudly introduces Dive Beer—a crisp, no-frills lager that channels the laid-back spirit of dive bars everywhere. Dive Beer offers a fresh take on what it means to enjoy a simple, satisfying brew. Crafted for beer enthusiasts who value simplicity and affordability, Dive Beer sets a new standard for the sub-premium beer market. At 4.0% ABV, it’s the ideal lager to dive into long nights and shared moments, offering a clean, crisp flavor that is both refreshing and well-balanced.

New 16oz Lager out now
Key Features of SweetWater’s Dive Beer:

Clean, crisp flavor using Crystal and Hallertau hops alongside Pilsner grains

4.0% ABV, perfect for long nights and shared moments

Affordable price point, making premium taste accessible to everyone

Dive Beer has already made its mark in blind taste tests, outpacing top competitors in drinkability, refreshment, and overall preference. Its affordable price point ensures that premium taste is within reach for everyone, from craft beer enthusiasts to casual drinkers alike.

READ MORE

 

Blüm Holdings Moves Forward with Binding LOI for Key Acquisition


DOWNEY, Calif., Feb. 04, 2025 — Blum Holdings, Inc. (OTCQB: BLMH) (the “Company,” “Blüm,” “Blüm Holdings,” “we” or “us”), a California-based publicly traded holding company and cannabis operator, today announced that it has entered into a Binding Letter of Intent (“LOI”) to acquire a premier Northern California dispensary (“Target”). This follows the previously announced Non-Binding Letter of Intent disclosed in the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission (the “SEC”) on January 15, 2025.

For the twelve months ended December 31, 2024, the Target generated approximately $18.0 million in annual gross revenue and approximately $13.0 million in net revenue. These revenue figures have not been audited and remain subject to adjustment.

Pursuant to the terms of the LOI, a wholly own subsidiary of Blüm will acquire 100% of the issued and outstanding stock of the Target for a total purchase price of $2.0 million structured as a combination of cash and equity, and subject to a performance-based bonus award.

READ MORE

 

Optimi Health Completes Largest MDMA Capsule Batch to Date, Expands Stability Program

Over 4,000 GMP Capsules Ready to Support PTSD Treatment in Australia, Israel, and Canada

VANCOUVER, BC – January 29, 2025 – Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a Canadian-based company licensed by Health Canada to produce and supply natural, GMP-grade psilocybin and MDMA, has completed its largest production batch of MDMA to date—over 4,000 GMP capsules, enough to treat more than 1,000 patients.

As part of its commitment to ensuring long-term product stability and quality, Optimi has also completed one year of stability data on previously manufactured MDMA capsules, validating a one-year shelf life and extending the usability of its existing inventory for clinical and therapeutic applications. Additionally, the company has initiated a two-year stability program to further validate the long-term quality and reliability of its MDMA capsules.

With a growing number of authorized physicians prescribing Optimi’s MDMA for PTSD in Australia, increasing demand for Special Access Program (SAP) requests in Canada, and a key Phase 2 clinical trial initiative for PTSD in Israel, Optimi is one of the few companies able to both manufacture its psychedelic drugs in-house and export cost-effective, GMP-grade MDMA capsules globally.

READ MORE

 

BELOW ARE THE  LINKS TO THE DIRECTORY OF FLORIDA CANNABIS DOCTORS AND

DISPENSARIES IN THE STATE OF FLORIDA

Link to current Qualified Medical Marijuana Physicians in Florida>

Listing of MMTC dispensing facilities>

 
 

 QUALIFIED PATIENTS

OVER 900,000

AND

707

DISPENSING LOCATIONS

Image

LATEST OMMU REPORTS FROM OFFICE OF MEDICAL  MARIJUANA USE IN THE STATE OF FLORIDA

Highlights from 
FEBRUARY 7, 2025

Report 

BY THE NUMBERS

Qualified Patients: (Active ID Card)

FEB     07, 2025-             900,625

JAN     31, 2025-             900,540

JAN     24, 2025-             899,118

JAN     17, 2025-             898,322

JAN     10,  2025-            896,635          

JAN     03,  2025-            895,469

 

Patients Last Week: 85

Qualified Ordering Physicians: 2,455

New Doctors Last Week: -32

 

Reporting Period:  JAN 31 - FEB 6, 2025 

Amount of Medical Marijuana Dispensed -  (mgs THC)  362,863,071

Amount of Low-THC Cannabis Dispensed -  (mgs CBD) 45,362

Amount of Marijuana in a From for Smoking (oz) 127,453.330

Approved Dispensing Locations: 707

 

Added Last Week: 1

 

GOLDFLOWER - TAMPA

CLICK HERE FOR CURRENT OMMU REPORT
Alternate text
 

UPCOMING MEETING AND CONFERENCES

 
 
 
https://www.cannectd.com/
 
 

 In Case You Missed It:

Watch the MedCannCon24 Conference Recording!

We are excited to announce that the recording of SCC's October 2024 Medical Cannabis Conference is now available for purchase. 

 

This 2nd annual event brought together clinicians, researchers, experts, and advocates in the medical cannabis space to share groundbreaking insights, clinical applications, and the latest updates in cannabis science and policy. If you were unable to attend the conference or watch the livestream, this is your chance to access the wealth of information presented. 

 

All proceeds from this recording will support our mission to provide continuing education about the medical uses of cannabis and best practices in clinical care. 

 

View the conference agenda HERE.  

 

Thank you for your continued support in helping us build a more informed and empowered community!

 

Click the link below to purchase the recording. 

 

PURCHASE THE RECORDING

 
 

ADVERTISEMENT OPPORTUNITIES

 

If your goal is to get your business in front of the right people in the cannabis industry or you want to be an integral part of this new and exciting business opportunity, then you need to join with Cannabis News Florida as we help to establish cannabis as a major part of the economy in Florida. Cannabis News Florida is an online publication focusing on both local and national news from leading authorities about the medical and business developments in the medical cannabis industry covering the entire state of Florida.

 

Join the Cannabis News Florida force online and in print. We offer several marketing options to fit all budgets:

· MMTC PROMOS LISTED IN EACH E-NEWSLETTER 
• Directory Listing
• Banner Ads
• Ad Space in the Newspaper
• Feature Articles
• Weekly Newsletters


For further information or to make your ad reservation, please call:561-368-6950 / 954-605-4785 cell charles@cannabisnewsflorida.com

 

Click Here to Unsubscribe

 

CANNABIS NEWS FLORIDA

{YOURCOMPANY.ADDRESS}

{COPYRIGHT.YEAR}